NYXH Nyxoah
Company Analysis
Latest News
π’ Nyxoah is trading 5.7% up in pre-market with no fresh company-specific catalyst identified
Nyxoah is trading $1.67 (+5.70%) up now after no fresh company-specific catalyst was identified for August 14, 2026. β’ The latest identifiable company update...
π’ Nyxoah is trading 5.78% up today as immediate catalyst remains unclear
Nyxoah is trading at $1.55 (+5.78%) as recent momentum follows its August 5 earnings report, though the immediate catalyst remains unclear. - No new...
Nyxoah downgraded to sell, following wider-than-expected quarterly loss
Wall Street Zen downgraded Nyxoah (NASDAQ: NYXH) from hold to sell on August 9, 2026. The rating change follows the companyβs second-quarter earnings report...
Nyxoah's Sleep Apnea Device Is Gaining Traction in the U.S. β But Can a $1.41 Stock Grow Into Its Ambitions?
Shares of Nyxoah jumped 7.6% to $1.41 as investors continued to digest second-quarter results showing the Belgian medtech company's implantable...
π’ Nyxoah is trading 8.78% up today after reiterated 2026 revenue guidance
Nyxoah is trading 8.78% up now at $1.43 as investors continue assessing its August 5 earnings report and August 6 call. - Q2 revenue reached β¬7.7 million;...
π’ Nyxoah is trading 7.63% up in pre-market after strong Q2 results
Nyxoah is trading 7.63% up in pre-market at $1.41 after investors continued to digest strong second-quarter results released on August 5. - Global revenue...
π΄ Nyxoah is trading 5.7% down today on continued heavy losses despite strong Q2 growth
Nyxoah is trading 5.7% down at $1.33 after its August 5, 2026 earnings release delivered strong revenue growth but continued heavy losses. - Q2 revenue...
π΄ Nyxoah is trading 5.7% down today after Q2 earnings release
Nyxoah is trading 5.7% down at $1.33 in pre-market following its second-quarter earnings release. β’ The company reported strong revenue growth driven by the...
π’ Nyxoah is trading 5.5% up today after Q2 revenue beat and reiterated guidance
Nyxoah is trading at $1.49 (+5.48%) after hours after reporting second-quarter 2026 revenue that significantly exceeded analyst estimates. β’ Quarterly revenue...
Nyxoah's second quarter revenue of β¬7.7 million beats estimates, driven by strong U.S. launch momentum.
Nyxoah reported second quarter global net revenue of β¬7.7 million, a significant increase from β¬1.3 million in the prior-year period, driven by the ongoing...
Nyxoah Q2 2026 Earnings Preview: What Analysts Expect on August 05, 2026
Nyxoah is expected to report a Q2 2026 loss of $0.47 per share on consensus revenue of $3.85 million, with the current $13.40 stock price trading significantly...
π΄ Nyxoah is trading 5.4% down today with no clear company-specific catalyst
Nyxoah is trading 5.4% down at $1.39 today amid a quiet news backdrop, with no fresh company-specific developments or major announcements hitting the tape. β’...